Gemifloxacin process and polymorphs

Abstract

The present invention provides a novel process for the preparation of gemifloxacin and its pharmaceutically acceptable acid addition salts in high yield. The present invention also relates to novel polymorphs of gemifloxacin free base and its hydrates to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also relates to infusion solutions of gemifloxacin and to processes for their preparation. Thus, 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphth-yridine-3-carboxylic acid is reacted with a mixture of acetic anhydride, acetic acid and boric acid to give borane compound, which is then treated with 4-Aminomethyl-3-methoxyimino-pyrrolidinium dimethanesulfonate in presence of triethylamine, followed by treatment with 3.5% sodium hydroxide solution to give gemifloxacin free base.

1 - 22 . (canceled) 
     
     
         23 . Gemifloxacin monohydrate. 
     
     
         24 . A process for the preparation of the gemifloxacin monohydrate of  claim 23 , which comprises drying wet gemifloxacin at 40-100° C. until the water content is reduced to 4.0-5.0% by weight. 
     
     
         25 . The process according to  claim 24 , wherein the drying is carried out at 50-70° C. 
     
     
         26 - 43 . (canceled) 
     
     
         44 . A pharmaceutical composition comprising gemifloxacin monohydrate and a pharmaceutically acceptable excipient. 
     
     
         45 - 58 . (canceled)